Related Experiment Videos
[Malignant histiocytosis associated with chronic hepatitis]
Orvosi Hetilap
|March 25, 1990
Summary
Malignant histiocytosis was successfully treated with splenectomy and chemotherapy, leading to a satisfactory patient condition 33 months post-surgery. Early intervention before systemic spread was key, though viral hepatitis worsened.
Area of Science:
- Oncology
- Hematology
- Surgical Pathology
Background:
- Malignant histiocytosis is a rare neoplastic proliferation of histiocytes.
- Treatment strategies often involve chemotherapy and, in select cases, surgical intervention.
Observation:
- A patient presented with malignant histiocytosis.
- The patient also had co-existing chronic viral hepatitis.
Findings:
- Successful treatment was achieved through splenectomy and chemotherapy.
- The patient remained in satisfactory condition 33 months after the procedure.
- The positive outcome is linked to the absence of systemic proliferation at the time of surgery.
Implications:
- Early surgical intervention in malignant histiocytosis may improve prognosis.
- Chemotherapy and splenectomy can be effective treatment modalities.
- Viral hepatitis may be exacerbated by treatment for malignant histiocytosis, requiring careful monitoring.